Clinical Trial Update: Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing linagliptin plus metformin versus linagliptin alone in newly diagnosed, untreated type 2 diabetes. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)
• metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2014-05-09